Amalgamated Bank’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.36M Sell
116,887
-10,286
-8% -$501K 0.04% 342
2026
Q1
$5.45M Sell
127,173
-336
-0.3% -$14.4K 0.04% 385
2025
Q4
$5.59M Sell
127,509
-9,075
-7% -$375K 0.04% 370
2025
Q3
$5.64M Buy
136,584
+332
+0.2% +$13.3K 0.04% 367
2025
Q2
$6M Buy
136,252
+2,331
+2% +$93.2K 0.05% 317
2025
Q1
$4.94M Sell
133,921
-8,226
-6% -$293K 0.04% 371
2024
Q4
$4.73M Buy
142,147
+2,435
+2% +$79K 0.04% 408
2024
Q3
$3.63M Sell
139,712
-10,305
-7% -$256K 0.03% 544
2024
Q2
$3.37M Sell
150,017
-18,465
-11% -$410K 0.03% 625
2024
Q1
$4M Sell
168,482
-63,427
-27% -$1.41M 0.03% 565
2023
Q4
$5.56M Buy
231,909
+7,476
+3% +$163K 0.04% 417
2023
Q3
$4.9M Sell
224,433
-2,060
-0.9% -$43.1K 0.04% 450
2023
Q2
$4.33M Sell
226,493
-9,418
-4% -$182K 0.04% 508
2023
Q1
$4.58M Sell
235,911
-27,208
-10% -$474K 0.04% 480
2022
Q4
$4.22M Buy
263,119
+21,377
+9% +$349K 0.04% 572
2022
Q3
$3.79M Buy
241,742
+5,513
+2% +$107K 0.04% 526
2022
Q2
$4.92M Buy
236,229
+3,670
+2% +$75.6K 0.05% 422
2022
Q1
$5.27M Sell
232,559
-1,136
-0.5% -$22.2K 0.04% 452
2021
Q4
$4.27M Buy
233,695
+10,133
+5% +$194K 0.03% 598
2021
Q3
$4.73M Sell
223,562
-22,590
-9% -$419K 0.04% 531
2021
Q2
$4.49M Buy
246,152
+199,970
+433% +$4.66M 0.04% 602
2021
Q1
$1.04M Sell
46,182
-3,432
-7% -$77.5K 0.04% 534
2020
Q4
$996K Buy
49,614
+702
+1% +$14.7K 0.04% 542
2020
Q3
$1.2M Sell
48,912
-778
-2% -$18.2K 0.05% 368
2020
Q2
$1.18M Sell
49,690
-22,813
-31% -$529K 0.05% 352
2020
Q1
$1.25M Sell
72,503
-939
-1% -$17.2K 0.03% 523
2019
Q4
$1.29M Buy
73,442
+4,777
+7% +$81K 0.02% 694
2019
Q3
$1.21M Buy
68,665
+3,489
+5% +$70.6K 0.03% 657
2019
Q2
$1.39M Sell
65,176
-4,292
-6% -$90K 0.03% 609
2019
Q1
$1.65M Buy
69,468
+931
+1% +$21.2K 0.04% 485
2018
Q4
$1.35M Buy
68,537
+25,740
+60% +$459K 0.04% 505
2018
Q3
$758K Sell
42,797
-28,410
-40% -$554K 0.02% 797
2018
Q2
$1.53M Buy
71,207
+8,734
+14% +$181K 0.04% 518
2018
Q1
$1.38M Buy
62,473
+4,688
+8% +$130K 0.04% 538
2017
Q4
$1.76M Buy
57,785
+3,141
+6% +$83.6K 0.05% 417
2017
Q3
$1.32M Buy
54,644
+757
+1% +$20.1K 0.04% 495
2017
Q2
$1.33M Buy
53,887
+25,757
+92% +$545K 0.04% 474
2017
Q1
$610K Sell
28,130
-5
-0% -$102 0.03% 717
2016
Q4
$419K Buy
28,135
+3,762
+15% +$54.3K 0.02% 943
2016
Q3
$312K Buy
24,373
+51
+0.2% +$551 0.02% 992
2016
Q2
$259K Buy
24,322
+591
+2% +$3.4K 0.02% 1105
2016
Q1
$95K Buy
23,731
+2,138
+10% +$9.05K 0.01% 1230
2015
Q4
$122K Sell
21,593
-2,091
-9% -$11.7K 0.02% 1136
2015
Q3
$133K Buy
23,684
+3,403
+17% +$18.5K 0.01% 1213
2015
Q2
$76K Buy
20,281
+498
+3% +$1.62K 0.01% 1318
2015
Q1
$51K Buy
19,783
+771
+4% +$1.79K 0.01% 919
2014
Q4
$27K Buy
19,012
+24
+0.1% +$37 ﹤0.01% 849
2014
Q3
$29K Sell
18,988
-9
-0% -$29 ﹤0.01% 834
2014
Q2
$64K Sell
18,997
-813
-4% -$2.81K 0.01% 855
2014
Q1
$70K Buy
19,810
+741
+4% +$5.04K 0.01% 808
2013
Q4
$117K Buy
+19,069
New +$105K 0.02% 798

Other funds holding EXEL

Amalgamated Bank's EXEL Position: Q2 2026 in Review

Amalgamated Bank reduced its Exelixis (EXEL) stake by 8.1% in Q2 2026, selling an estimated $501K and leaving 116,887 shares worth $6.36M. The position accounts for 0.04% of the portfolio, ranked #342.

Amalgamated Bank first reported a position in EXEL in Q4 2013 and has held it in 51 quarters since. 377 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Amalgamated Bank held 116,887 shares of Exelixis worth $6.36M as of Q2 2026.
  • Amalgamated Bank sold 10,286 Exelixis shares in Q2 2026, an estimated $501K.
  • Exelixis made up 0.04% of Amalgamated Bank's portfolio in Q2 2026, its #342 holding.
  • Amalgamated Bank first reported a position in Exelixis in Q4 2013 and has held it in 51 quarters since.
  • 377 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.